Line 250: | Line 250: | ||
<p style="text-indent:2em">Mosquito immune defense signaling involves well-studied and well-known Toll and Imd intracellular pathways to trigger antimicrobial peptide (AMP) production. Gram-positive bacteria induce Toll signaling, while Gram-negative bacteria induce Imd signaling. However, some promoters may be activated in a synergistic and cross-talk way. Even though Mosquito-borne viruses are controlled by immune signaling in mosquitoes in a currently unidentified pathway, AMP | <p style="text-indent:2em">Mosquito immune defense signaling involves well-studied and well-known Toll and Imd intracellular pathways to trigger antimicrobial peptide (AMP) production. Gram-positive bacteria induce Toll signaling, while Gram-negative bacteria induce Imd signaling. However, some promoters may be activated in a synergistic and cross-talk way. Even though Mosquito-borne viruses are controlled by immune signaling in mosquitoes in a currently unidentified pathway, AMP | ||
promoter activities were enhanced in mosquito cells in the presence of the viruses.</p> | promoter activities were enhanced in mosquito cells in the presence of the viruses.</p> | ||
− | + | ||
<p style="text-indent:2em"><i>Front Cell Infect Microbiol.</i> (2017) <b>Regulation of | <p style="text-indent:2em"><i>Front Cell Infect Microbiol.</i> (2017) <b>Regulation of | ||
Antimicrobial Peptides in Aedes aegypti Aag2 Cells.</b><br> | Antimicrobial Peptides in Aedes aegypti Aag2 Cells.</b><br> | ||
Line 260: | Line 260: | ||
↓RNA extracted 12 hours after bacteria challenge<br> | ↓RNA extracted 12 hours after bacteria challenge<br> | ||
↓qRT-PCR with specific AMP primers</p> | ↓qRT-PCR with specific AMP primers</p> | ||
− | + | ||
− | <h3> | + | <h3>RESULT</h3> |
− | <p style="text-indent:2em"> | + | <p style="text-indent:2em">AMP promoters can be activated by challenging with Gram-negative and Gram-positive bacteria. In addition, some are regulated synergistically by cross-talking Toll and Imd pathways.</p> |
− | + | ||
− | <h3> | + | <h3>REFERENCE</h3> |
− | <p | + | <p>1.Trends Parasitol. (2016) Mosquito Defense Strategies against |
− | + | Viral Infection.<br> | |
+ | 2.Front Cell Infect Microbiol. (2017) Regulation of Antimicrobial | ||
+ | Peptides in Aedes aegypti Aag2 Cells</p> | ||
<h3>What we do</h3> | <h3>What we do</h3> | ||
<p style="text-indent:2em">For our antidote, we synthesize enzymes that degrade aflatoxin to a large extent, as well as alleviate some of the DNA damage induced, to reduce the harm of aflatoxins. In addition, we also use yeast to express our recombinant proteins because it is a common and safe vector which is generally recognized as safe (GRAS) approved from FDA.</p> | <p style="text-indent:2em">For our antidote, we synthesize enzymes that degrade aflatoxin to a large extent, as well as alleviate some of the DNA damage induced, to reduce the harm of aflatoxins. In addition, we also use yeast to express our recombinant proteins because it is a common and safe vector which is generally recognized as safe (GRAS) approved from FDA.</p> |
Revision as of 06:41, 18 September 2018